Concept information
Preferred term
Pyridostigmine Bromide
Type
-
mesh:Descriptor
Definition
- A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
Broader concept
Entry terms
- 101-26-8 (Pyridostigmine Bromide)
- 19QM69HH21
- KVI301NA53
- Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-, bromide
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
101-26-8 (Pyridostigmine Bromide)
-
19QM69HH21
-
Bromure pyridostigmine
-
KVI301NA53
-
Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-, bromide
URI
http://data.loterre.fr/ark:/67375/JVR-FT1564MF-K
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}